Hyaluronan production increases the malignant properties of mesothelioma cells (original) (raw)

Abstract

Malignant pleural mesotheliomas is in most cases associated with elevated amounts of hyaluronan. To investigate the importance of hyaluronan for the malignant properties of mesotheliomas, we have expressed murine hyaluronan synthase 2 (HAS2) in the non-hyaluronan producing mesothelioma cell line, Mero-25. We found that upon hyaluronan overproduction the mesothelioma cells changed their epitheloid character to a fibroblastic phenotype and were surrounded by pericellular matrices, the size of which correlated to the amount of synthesized hyaluronan. HAS2-transfected cells with the ability to synthesize about 520 ng hyaluronan/5 × 104cells/24 h exhibited about a 2-fold increase in the expression of the cell surface hyaluronan receptor CD44 and their locomotion increased compared to that of mock-transfected Mero-25 cells. Furthermore, the malignant properties of mesothelioma cell clones as determined by the ability to grow in a soft agar assay correlated to their hyaluronan production. These results provide evidence for an important role of hyaluronan in the aggressive spread of mesotheliomas in adjacent non-cancerous stromal tissues. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: malignant mesothelioma, hyaluronan synthase, hyaluronan receptor, tumour spreading

Full Text

The Full Text of this article is available as a PDF (124.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asplund T., Heldin P. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res. 1994 Aug 15;54(16):4516–4523. [PubMed] [Google Scholar]
  2. Asplund T., Versnel M. A., Laurent T. C., Heldin P. Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts. Cancer Res. 1993 Jan 15;53(2):388–392. [PubMed] [Google Scholar]
  3. Auvinen P. K., Parkkinen J. J., Johansson R. T., Agren U. M., Tammi R. H., Eskelinen M. J., Kosma V. M. Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer. 1997 Oct 21;74(5):477–481. doi: 10.1002/(sici)1097-0215(19971021)74:5<477::aid-ijc1>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  4. Bertrand P., Girard N., Delpech B., Duval C., d'Anjou J., Dauce J. P. Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int J Cancer. 1992 Aug 19;52(1):1–6. doi: 10.1002/ijc.2910520102. [DOI] [PubMed] [Google Scholar]
  5. Bielefeldt-Ohmann H., Jarnicki A. G., Fitzpatrick D. R. Molecular pathobiology and immunology of malignant mesothelioma. J Pathol. 1996 Apr;178(4):369–378. doi: 10.1002/(SICI)1096-9896(199604)178:4<369::AID-PATH460>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  6. Brecht M., Mayer U., Schlosser E., Prehm P. Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J. 1986 Oct 15;239(2):445–450. doi: 10.1042/bj2390445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brinck J., Heldin P. Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. Exp Cell Res. 1999 Nov 1;252(2):342–351. doi: 10.1006/excr.1999.4645. [DOI] [PubMed] [Google Scholar]
  8. Clarris B. J., Fraser J. R. On the pericellular zone of some mammalian cells in vitro. Exp Cell Res. 1968 Jan;49(1):181–193. doi: 10.1016/0014-4827(68)90530-2. [DOI] [PubMed] [Google Scholar]
  9. Dahl I. M., Solheim O. P., Erikstein B., Müller E. A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease. Cancer. 1989 Jul 1;64(1):68–73. doi: 10.1002/1097-0142(19890701)64:1<68::aid-cncr2820640112>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  10. Delpech B., Girard N., Olivier A., Maingonnat C., van Driessche G., van Beeumen J., Bertrand P., Duval C., Delpech A., Bourguignon J. The origin of hyaluronectin in human tumors. Int J Cancer. 1997 Sep 17;72(6):942–948. doi: 10.1002/(sici)1097-0215(19970917)72:6<942::aid-ijc4>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  11. Forrester J. V., Wilkinson P. C. Inhibition of leukocyte locomotion by hyaluronic acid. J Cell Sci. 1981 Apr;48:315–331. doi: 10.1242/jcs.48.1.315. [DOI] [PubMed] [Google Scholar]
  12. Freedman V. H., Shin S. I. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell. 1974 Dec;3(4):355–359. doi: 10.1016/0092-8674(74)90050-6. [DOI] [PubMed] [Google Scholar]
  13. Frizelle S. P., Grim J., Zhou J., Gupta P., Curiel D. T., Geradts J., Kratzke R. A. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression. Oncogene. 1998 Jun 18;16(24):3087–3095. doi: 10.1038/sj.onc.1201870. [DOI] [PubMed] [Google Scholar]
  14. Heldin P., Pertoft H. Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. Exp Cell Res. 1993 Oct;208(2):422–429. doi: 10.1006/excr.1993.1264. [DOI] [PubMed] [Google Scholar]
  15. Heldin P., Suzuki M., Teder P., Pertoft H. Chondroitin sulfate proteoglycan modulates the permeability of hyaluronan-containing coats around normal human mesothelial cells. J Cell Physiol. 1995 Oct;165(1):54–61. doi: 10.1002/jcp.1041650107. [DOI] [PubMed] [Google Scholar]
  16. Itano N., Kimata K. Molecular cloning of human hyaluronan synthase. Biochem Biophys Res Commun. 1996 May 24;222(3):816–820. doi: 10.1006/bbrc.1996.0827. [DOI] [PubMed] [Google Scholar]
  17. Itano N., Sawai T., Yoshida M., Lenas P., Yamada Y., Imagawa M., Shinomura T., Hamaguchi M., Yoshida Y., Ohnuki Y. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem. 1999 Aug 27;274(35):25085–25092. doi: 10.1074/jbc.274.35.25085. [DOI] [PubMed] [Google Scholar]
  18. Jacobson A., Brinck J., Briskin M. J., Spicer A. P., Heldin P. Expression of human hyaluronan synthases in response to external stimuli. Biochem J. 2000 May 15;348(Pt 1):29–35. [PMC free article] [PubMed] [Google Scholar]
  19. Kimata K., Honma Y., Okayama M., Oguri K., Hozumi M., Suzuki S. Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. Cancer Res. 1983 Mar;43(3):1347–1354. [PubMed] [Google Scholar]
  20. Klominek J., Robért K. H., Hjerpe A., Wickström B., Gahrton G. Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res. 1989 Nov 1;49(21):6118–6122. [PubMed] [Google Scholar]
  21. Knudson W. The role of CD44 as a cell surface hyaluronan receptor during tumor invasion of connective tissue. Front Biosci. 1998 Jul 1;3:d604–d615. doi: 10.2741/a305. [DOI] [PubMed] [Google Scholar]
  22. Kosaki R., Watanabe K., Yamaguchi Y. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. Cancer Res. 1999 Mar 1;59(5):1141–1145. [PubMed] [Google Scholar]
  23. Laurent T. C., Fraser J. R. Hyaluronan. FASEB J. 1992 Apr;6(7):2397–2404. [PubMed] [Google Scholar]
  24. Laurent T. C., Laurent U. B., Fraser J. R. Functions of hyaluronan. Ann Rheum Dis. 1995 May;54(5):429–432. doi: 10.1136/ard.54.5.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lebel L., Smith L., Risberg B., Gerdin B., Laurent T. C. Effect of increased hydrostatic pressure on lymphatic elimination of hyaluronan from sheep lung. J Appl Physiol (1985) 1988 Apr;64(4):1327–1332. doi: 10.1152/jappl.1988.64.4.1327. [DOI] [PubMed] [Google Scholar]
  26. Li Y., Rahmanian M., Widström C., Lepperdinger G., Frost G. I., Heldin P. Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and induction of types I and III collagen gene expression. Am J Respir Cell Mol Biol. 2000 Sep;23(3):411–418. doi: 10.1165/ajrcmb.23.3.4102. [DOI] [PubMed] [Google Scholar]
  27. Metcalf R. A., Welsh J. A., Bennett W. P., Seddon M. B., Lehman T. A., Pelin K., Linnainmaa K., Tammilehto L., Mattson K., Gerwin B. I. p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res. 1992 May 1;52(9):2610–2615. [PubMed] [Google Scholar]
  28. Naor D., Sionov R. V., Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res. 1997;71:241–319. doi: 10.1016/s0065-230x(08)60101-3. [DOI] [PubMed] [Google Scholar]
  29. Nurse P. Universal control mechanism regulating onset of M-phase. Nature. 1990 Apr 5;344(6266):503–508. doi: 10.1038/344503a0. [DOI] [PubMed] [Google Scholar]
  30. Ropponen K., Tammi M., Parkkinen J., Eskelinen M., Tammi R., Lipponen P., Agren U., Alhava E., Kosma V. M. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res. 1998 Jan 15;58(2):342–347. [PubMed] [Google Scholar]
  31. Scarpa S., Giuffrida A., Fazi M., Coletti A., Palumbo C., Pass H. I., Procopio A., Modesti A. Migration of mesothelioma cells correlates with histotype-specific synthesis of extracellular matrix. Int J Mol Med. 1999 Jul;4(1):67–71. doi: 10.3892/ijmm.4.1.67. [DOI] [PubMed] [Google Scholar]
  32. Shyjan A. M., Heldin P., Butcher E. C., Yoshino T., Briskin M. J. Functional cloning of the cDNA for a human hyaluronan synthase. J Biol Chem. 1996 Sep 20;271(38):23395–23399. doi: 10.1074/jbc.271.38.23395. [DOI] [PubMed] [Google Scholar]
  33. Spicer A. P., Augustine M. L., McDonald J. A. Molecular cloning and characterization of a putative mouse hyaluronan synthase. J Biol Chem. 1996 Sep 20;271(38):23400–23406. doi: 10.1074/jbc.271.38.23400. [DOI] [PubMed] [Google Scholar]
  34. Spicer A. P., Olson J. S., McDonald J. A. Molecular cloning and characterization of a cDNA encoding the third putative mammalian hyaluronan synthase. J Biol Chem. 1997 Apr 4;272(14):8957–8961. doi: 10.1074/jbc.272.14.8957. [DOI] [PubMed] [Google Scholar]
  35. Teder P., Versnel M. A., Heldin P. Stimulatory effects of pleural fluids from mesothelioma patients on CD44 expression, hyaluronan production and cell proliferation in primary cultures of normal mesothelial and transformed cells. Int J Cancer. 1996 Jul 29;67(3):393–398. doi: 10.1002/1097-0215(19960729)67:3<393::aid-ijc2910670302>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  36. Tengblad A. Quantitative analysis of hyaluronate in nanogram amounts. Biochem J. 1980 Jan 1;185(1):101–105. doi: 10.1042/bj1850101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Thomas L., Byers H. R., Vink J., Stamenkovic I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol. 1992 Aug;118(4):971–977. doi: 10.1083/jcb.118.4.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Thylén A., Levin-Jacobsen A. M., Hjerpe A., Martensson G. Immunohistochemical differences between hyaluronan- and non-hyaluronan-producing malignant mesothelioma. Eur Respir J. 1997 Feb;10(2):404–408. doi: 10.1183/09031936.97.10020404. [DOI] [PubMed] [Google Scholar]
  39. Thylén A., Wallin J., Martensson G. Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma. Cancer. 1999 Nov 15;86(10):2000–2005. [PubMed] [Google Scholar]
  40. Versnel M. A., Bouts M. J., Hoogsteden H. C., van der Kwast T. H., Delahaye M., Hagemeijer A. Establishment of human malignant mesothelioma cell lines. Int J Cancer. 1989 Aug 15;44(2):256–260. doi: 10.1002/ijc.2910440212. [DOI] [PubMed] [Google Scholar]
  41. Vindeløv L. L., Christensen I. J., Nissen N. I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983 Mar;3(5):323–327. doi: 10.1002/cyto.990030503. [DOI] [PubMed] [Google Scholar]
  42. Watanabe K., Yamaguchi Y. Molecular identification of a putative human hyaluronan synthase. J Biol Chem. 1996 Sep 20;271(38):22945–22948. doi: 10.1074/jbc.271.38.22945. [DOI] [PubMed] [Google Scholar]
  43. Yu Q., Toole B. P., Stamenkovic I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med. 1997 Dec 15;186(12):1985–1996. doi: 10.1084/jem.186.12.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zhang L., Underhill C. B., Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res. 1995 Jan 15;55(2):428–433. [PubMed] [Google Scholar]